Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
1995
DOI: 10.1006/cimm.1995.1205
|View full text |Cite
|
Sign up to set email alerts
|

Administration of Monoclonal Antibodies against Vascular Cell Adhesion Molecule-1/Very Late Antigen-4 Abrogates Predisposing Autoimmune Diabetes in NOD Mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
13
0

Year Published

1997
1997
2011
2011

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(14 citation statements)
references
References 0 publications
1
13
0
Order By: Relevance
“…Consistent with our observation, the adoptive transfer of diabetes in the NOD mouse can be delayed by treatment with anti-VCAM-1 (24,56). Therefore, the blockade of VCAM-1 may represent a potential therapeutic treatment for T1DM.…”
Section: Discussionsupporting
confidence: 85%
“…Consistent with our observation, the adoptive transfer of diabetes in the NOD mouse can be delayed by treatment with anti-VCAM-1 (24,56). Therefore, the blockade of VCAM-1 may represent a potential therapeutic treatment for T1DM.…”
Section: Discussionsupporting
confidence: 85%
“…These models include spontaneously occurring diabetes in the NOD mouse (30), asthma (31), and conjunctivitis (32). VLA-4 also has been shown to play an integral part in allograft rejection (33), and Ab's targeting it and other adhesion molecules have been the focus of attempts to induce immunosuppression in transplant recipients (34).…”
Section: Figurementioning
confidence: 99%
“…Seven-day-old NOD mice were injected intraperitoneally with 500 m g of either R1-2; anti-a4-integrin and M/K2; anti-vascular cell adhesion molecule-1 (VCAM-1) mAbs [13] or KAT-1; anti-intercellular adhesion molecule-1 (ICAM-1) and KBA; anti-leukocyte function-associated antigen-1 (LFA-1) mAbs [14] ) were preincubated with 10 m g/ml relevant mAbs for 30 min at 4°C before injection into corresponding mAbspretreated NOD recipients. Diabetic incidence was monitored up to 7 days after transfer and pancreatic insulitis of four mice in each group was evaluated at 3 days after transfer.…”
Section: Adoptive Transfer Of Diabetes By Cd8 T-cell Clonesmentioning
confidence: 99%
“…Diabetic incidence was monitored up to 7 days after transfer and pancreatic insulitis of four mice in each group was evaluated at 3 days after transfer. The severity of insulitis was assessed by using the scoring system as follows [13,14]: 0) normal islets; 1) mononuclear cell infiltration in less than 25 % of the islets; 2) 25-50 % of the islet infiltrated; 3) over 50 % infiltrated; 4) small retracted islets with few mononuclear cells.…”
Section: Adoptive Transfer Of Diabetes By Cd8 T-cell Clonesmentioning
confidence: 99%